Key Figures Q2 2004

Key Figures provide a succinct overview of the most significant developments for each period under review. You can view earlier quarters or years if you wish. Furthermore, you can find extensive reports by downloading press releases for the period of your choice.

Strong growth and clearly better result in second quarter

• Operating profit of EUR 133 million above the level of Q2 2003 (+56%) and Q1 2004 (+21%).
• Net profit of EUR 97 million up 43% from Q2 2003 and 23% from Q1 2004.
• Strong contribution from DSM Nutritional Products.
• 18% Volume growth at Performance Materials and Industrial Chemicals.
• Result of Life Science Products remains under pressure from the poor antibiotics market.
• Interim dividend EUR 0.58 per ordinary share.
• Outlook for 2004: profit on ordinary activities after taxation substantially higher than in 2003.